This report provides exclusive insights into the COVID-19 impact on the Cardiac Biomarker Diagnostic Kits Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cardiac Biomarker Diagnostic Kits Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cardiac Biomarker Diagnostic Kits Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
report published by Infinium Global Research on cardiac biomarker diagnostic
kits market provides in-depth analysis of segments and sub-segments in the
global as well as regional cardiac biomarker diagnostic kits market. The study
also highlights the impact of drivers, restraints, and macro indicators on the
global and regional cardiac biomarker diagnostic kits market over the short
term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global cardiac biomarker diagnostic kits market.
According to the report, the global cardiac biomarker diagnostic kits market is
projected to grow at a CAGR of 8.23% over the forecast period of 2019-2025.
A biomarker is a type of indicator, used to measure the degree of
severity of any disease inside the living body. The cardiac biomarker is a
substance, which is used to measure the seriousness of the cardiac problem and
assist the healthcare professionals for better diagnosis to the patients. There
are several types of cardiac biomarker used for different cardiac problems such
as cardiac troponin, high sensitive cardiac troponin, CK, CK-MB, myoglobin, and
others. The cardiac troponin is a regulatory protein complex, used to diagnose
a heart attack and risk stratification. Additionally, it is used to identify
the seriousness of the heart problem. The high sensitive cardiac troponin is
used to assess the future risk of the cardiac problem in the person. Further,
the CK biomarker is used to detect the recurrence of the heart attack in the
patients. Moreover, the myoglobin is used with troponin to provide a diagnosis
as early as possible.
As per the
WHO the CVD (Cardiovascular diseases) is a major cause of death from disease
around the world. In 2016, 17.9 million people died from the CVDs problem,
which comprises of 31% of the global death from illness. Further, 85% of death
due to CVDs was due to heart attack and stroke. The developing and under
developing countries reported more death owing to the CVDs problem compared to
the developed countries. The lack of basic healthcare infrastructure, shortage
of healthcare professionals in the developing and underdeveloped countries are
the key factors for more death in these regions as compared to the developed
countries. The changing food consumption and living standard is a major factor
for the growth of this type of disease around the globe. The growing
consumption of nicotine, growing alcoholism, lack of physical activities, the stressful work environment is the major factor responsible for the increasing
prevalence of the cardiac problem around the world.
America is the leading region of the cardiac biomarker diagnostic kits market, owing to the
presence of the large patient pool in this region. As per the American Heart
Association, more than 320,000 deaths (out of hospital) occurs every year, in
the United States due to the cardiac-related problem. Further, more than
7,20,000 new heart attack and 3,35,000 recurrent heart attack occurs every year
in the United States alone. Additionally, persons suffering from this type of
problem in other countries as Indian, China prefer to go to the United States
of America to get better treatment, owing to the availability of the better
health care facility and trained health care professionals. This medical
tourism is boosting the growth of the cardiac biomarker diagnostic kits market of the North
America. Europe region is the second largest market after North America.
The Asia-Pacific is expected to show the high incidence of the cardiac problem
in the near future, owing to the changing lifestyle. Further, changing food
consumption as smoking, drinking, and fast food preference is increasing the
incidence of the cardiac arrest problem in this region.
The report on
global cardiac biomarker diagnostic kits market covers segments such as disease
indication, testing, product, and end user. On the basis of disease indication,
the sub-markets include angina pectoris, myocardial infraction, cardiac heart
failure, and other disease indication. On the basis of testing, the sub-markets
include laboratory testing, and point of care testing. On the basis of product,
the sub-markets include troponin test kits, CK-MB test kits, myoglobin test
kits, BNP test kit, c-reactive protein (HSCRP), and other products. On the
basis of end user, the sub-markets include hospitals, clinics, diagnostics
centers, and other end users.
provides profiles of the companies in the market such as Ortho Clinical
Diagnostics, Randox Laboratories, bioMérieux, Thermo Fisher Scientific, Siemens
Healthineers AG, Danaher Corporation, Bio-Rad Laboratories, Inc., F.
Hoffmann-La Roche AG, and Abbott Laboratories.
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of cardiac biomarker diagnostic kits market.
Moreover, the study highlights current market trends and provides forecast from
2019-2025. We also have highlighted future trends in the market that will
affect the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share
of the leading players.